Hiroshi Nishiyama Selected Research

Intercellular Signaling Peptides and Proteins (Growth Factors)

1/2012

Association between growth factor heregulin1α and receptors in growth of ovarian cancer cell line with high potentiality of peritoneal dissemination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Nishiyama Research Topics

Disease

18	Neoplasms (Cancer) 01/2023 - 01/2011
8	Ovarian Neoplasms (Ovarian Cancer) 08/2017 - 01/2011
7	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2016
6	Body Weight (Weight, Body) 01/2024 - 01/2011
3	Obesity 01/2023 - 02/2004
3	Carcinosarcoma 06/2015 - 12/2014
2	Myocardial Infarction 01/2024 - 01/2022
2	Stroke (Strokes) 01/2024 - 01/2022
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 04/2023 - 03/2014
2	Hypoglycemia (Reactive Hypoglycemia) 09/2021 - 04/2017
2	Disease Progression 08/2017 - 12/2014
2	Sarcoma (Soft Tissue Sarcoma) 01/2015 - 12/2014
2	Endometrioid Carcinoma 03/2014 - 04/2008
2	Inflammation (Inflammations) 02/2014 - 03/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2024
1	Unstable Angina 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2021
1	Endometrial Neoplasms (Endometrial Cancer) 09/2020
1	Fatigue 09/2020
1	Mental Fatigue 09/2020
1	Diabetes Mellitus 09/2020
1	Overweight 07/2020
1	Hyperlipidemias (Hyperlipidemia) 07/2020
1	Diarrhea 09/2017
1	Short Bowel Syndrome 09/2017
1	Pain (Aches) 01/2016
1	Weight Loss (Weight Reduction) 01/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2015
1	Neutropenia 05/2014
1	Ovarian Epithelial Carcinoma 03/2014
1	Malnutrition (Nutritional Deficiencies) 03/2013
1	Wounds and Injuries (Trauma) 11/2012
1	Hemorrhage 11/2012
1	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2011

Drug/Important Bio-Agent (IBA)

4	PlatinumIBA 08/2017 - 01/2011
3	dulaglutideIBA 01/2024 - 01/2016
3	Insulin Lispro (Humalog)FDA Link 09/2021 - 09/2020
3	Irinotecan (Camptosar)FDA LinkGeneric 08/2017 - 01/2011
3	taxaneIBA 08/2017 - 01/2011
2	Blood Glucose (Blood Sugar)IBA 01/2024 - 08/2018
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2024 - 01/2022
2	tirzepatideIBA 01/2024 - 01/2022
2	omega-Chloroacetophenone (Mace)IBA 01/2024 - 01/2022
2	LipidsIBA 07/2020 - 09/2017
2	HDL CholesterolIBA 07/2020 - 04/2017
2	LDL CholesterolIBA 07/2020 - 04/2017
2	Triglycerides (Triacylglycerol)IBA 09/2017 - 04/2017
2	1-dodecylpyridoxal (PLD)IBA 08/2017 - 05/2014
2	liposomal doxorubicin (Doxil)FDA Link 08/2017 - 05/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2015 - 12/2014
2	Carboplatin (JM8)FDA LinkGeneric 01/2015 - 12/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2014 - 03/2013
2	C-Reactive ProteinIBA 02/2014 - 03/2013
2	CytokinesIBA 02/2014 - 12/2006
1	MicroRNAs (MicroRNA)IBA 01/2023
1	claudin 6IBA 09/2020
1	ClaudinsIBA 09/2020
1	AntioxidantsIBA 09/2020
1	CholesterolIBA 07/2020
1	Insulin Glargine (Lantus)FDA Link 08/2018
1	Dietary Fiber FDA Link 09/2017
1	LecithinsIBA 09/2017
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2017
1	oxidized low density lipoproteinIBA 04/2017
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2017
1	Malondialdehyde (Propanedial)IBA 04/2017
1	Hyaluronic Acid (Hyaluronan)IBA 01/2016
1	BiguanidesIBA 01/2016
1	Taxoids (Taxanes)IBA 03/2014
1	Interleukin-17 (Interleukin 17)IBA 02/2014
1	Proteins (Proteins, Gene)FDA Link 02/2014
1	Prorenin ReceptorIBA 01/2014
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2013
1	Cisplatin (Platino)FDA LinkGeneric 01/2013
1	IntegrinsIBA 02/2012
1	histidine-rich proteinsIBA 01/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2012
1	ramelteon (Rozerem)FDA Link 02/2011
1	Etoposide (VP 16)FDA LinkGeneric 01/2011
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 09/2007
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 09/2007
1	Phosphodiesterase InhibitorsIBA 09/2007
1	4- bromo- 6- (3- (4- chlorophenyl)propoxy)- 5- (3- pyridylmethylamino)- 3(2H)- pyridazinone hydrochlorideIBA 09/2007

Therapy/Procedure

6	Therapeutics 08/2017 - 11/2013
5	Drug Therapy (Chemotherapy) 08/2017 - 01/2012
2	Lymph Node Excision (Lymph Node Dissection) 04/2023 - 04/2008
2	Trachelectomy 08/2015 - 08/2015
2	Hysterectomy 12/2014 - 04/2008
1	Subcutaneous Injections 01/2024
1	Injections 05/2020
1	Enteral Nutrition (Feeding, Tube) 09/2017
1	Glycemic Control 01/2016
1	Radiotherapy 01/2015
1	Cystectomy 01/2015
1	Salpingo-oophorectomy 12/2014
1	Drug Tapering 05/2014
1	Blood Transfusion (Blood Transfusions) 11/2012
1	Dilatation and Curettage 11/2012
1	Therapeutic Abortion 11/2012
1	Combination Drug Therapy (Combination Chemotherapy) 01/2011